Drug profile · INN
bifikafusp alfa
NIDLEGY
bifikafusp alfa (NIDLEGY) is an FDA-listed pharmaceutical active ingredient.
EMA: application withdrawn Antineoplastic and immunomodulating agents (L01) L01XY
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — bifikafusp alfa
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
bifikafusp alfa (NIDLEGY) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN bifikafusp alfa
Brand NIDLEGY
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XY
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is bifikafusp alfa?
bifikafusp alfa (NIDLEGY) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for bifikafusp alfa?
NIDLEGY is a marketed brand name for bifikafusp alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.